These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34488880)

  • 21. An Innovative, Paradigm-Shifting Lifestyle Intervention to Reduce Glucose Excursions With the Use of Continuous Glucose Monitoring to Educate, Motivate, and Activate Adults With Newly Diagnosed Type 2 Diabetes: Pilot Feasibility Study.
    Oser TK; Cucuzzella M; Stasinopoulos M; Moncrief M; McCall A; Cox DJ
    JMIR Diabetes; 2022 Feb; 7(1):e34465. PubMed ID: 35050857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes.
    Ohara M; Hiromura M; Nagaike H; Kohata Y; Fujikawa T; Goto S; Sato N; Kushima H; Terasaki M; Yamamoto T; Mori Y; Hayashi T; Fukui T; Yamagishi SI; Hirano T
    Diabetes Res Clin Pract; 2019 Dec; 158():107904. PubMed ID: 31672500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impacts of glycemic variability on the relationship between glucose management indicator from iPro
    Liu H; Yang D; Deng H; Xu W; Lv J; Zhou Y; Luo S; Zheng X; Liang H; Yao B; Qiu L; Wang F; Liu F; Yan J; Weng J
    Ther Adv Endocrinol Metab; 2020; 11():2042018820931664. PubMed ID: 32551036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there an optimal strategy for real-time continuous glucose monitoring in pediatrics? A 12-month French multi-center, prospective, controlled randomized trial (Start-In!).
    Guilmin-Crépon S; Carel JC; Schroedt J; Sulmont V; Salmon AS; Le Tallec C; Coutant R; Dalla-Vale F; Stuckens C; Bony-Trifunovic H; Crosnier H; Kurtz F; Kaguelidou F; Le Jeannic A; Durand-Zaleski I; Couque N; Alberti C; Tubiana-Rufi N
    Pediatr Diabetes; 2019 May; 20(3):304-313. PubMed ID: 30663187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial.
    Majithia AR; Kusiak CM; Armento Lee A; Colangelo FR; Romanelli RJ; Robertson S; Miller DP; Erani DM; Layne JE; Dixon RF; Zisser H
    J Med Internet Res; 2020 Aug; 22(8):e21778. PubMed ID: 32856597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.
    Foreman YD; Brouwers MCGJ; van der Kallen CJH; Pagen DME; van Greevenbroek MMJ; Henry RMA; Koster A; Wesselius A; Schaper NC; Stehouwer CDA
    Diabetes Technol Ther; 2020 May; 22(5):395-403. PubMed ID: 31886732
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of continuous glucose monitoring for type 2 in diabetes management and research.
    Vigersky R; Shrivastav M
    J Diabetes Complications; 2017 Jan; 31(1):280-287. PubMed ID: 27818105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM).
    Matsumura M; Nakatani Y; Tanka S; Aoki C; Sagara M; Yanagi K; Suzuki K; Aso Y
    Diabetes Ther; 2017 Aug; 8(4):821-827. PubMed ID: 28646412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Hyperglycemia, Hypoglycemia and Inter-Day Glucose Variability Using Continuous Glucose Monitoring among Diabetic Patients on Chronic Hemodialysis.
    Divani M; Georgianos PI; Didangelos T; Liakopoulos V; Makedou K; Iliadis F; Savopoulos C; Grekas DM
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USE OF CONTINUOUS GLUCOSE MONITORING LEADS TO DIAGNOSIS OF HEMOGLOBIN C TRAIT IN A PATIENT WITH DISCREPANT HEMOGLOBIN A1C AND SELF-MONITORED BLOOD GLUCOSE.
    Wright JJ; Hu JR; Shajani-Yi Z; Bao S
    AACE Clin Case Rep; 2019; 5(1):e31-e34. PubMed ID: 31966996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of continuous glucose monitoring of blood glucose control in patients with diabetes undergoing hemodialysis: A pilot study.
    Lee S; Lee S; Kim KM; Shin JH
    Front Med (Lausanne); 2023; 10():1145470. PubMed ID: 37089609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Declining ß-cell function is associated with the lack of long-range negative correlation in glucose dynamics and increased glycemic variability: A retrospective analysis in patients with type 2 diabetes.
    Kohnert KD; Heinke P; Vogt L; Augstein P; Salzsieder E
    J Clin Transl Endocrinol; 2014 Dec; 1(4):192-199. PubMed ID: 29159101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous glucose monitoring reveals similar glycemic variability in individuals with obesity despite increased HOMA-IR.
    Cooper DJ; Zarabi S; Farrand B; Becker A; Roslin M
    Front Nutr; 2022; 9():1070187. PubMed ID: 36570168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous subcutaneous glucose monitoring shows a close correlation between mean glucose and time spent in hyperglycemia and hemoglobin A1c.
    Nielsen JK; Gravholt CH; Djurhuus CB; Brandt D; Becker J; Heinemann L; Christiansen JS
    J Diabetes Sci Technol; 2007 Nov; 1(6):857-63. PubMed ID: 19885157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Professional continuous glucose monitoring and endocrinology eConsult for adults with type 2 diabetes in primary care: Results of a clinical pilot program.
    Fantasia KL; Stockman MC; Ju Z; Ortega P; Crable EL; Drainoni ML; Walkey AJ; Bergstrom M; O'Brien K; Steenkamp D
    J Clin Transl Endocrinol; 2021 Mar; 24():100254. PubMed ID: 33898271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive wearables for remote monitoring of HbA1c and glucose variability: proof of concept.
    Bent B; Cho PJ; Wittmann A; Thacker C; Muppidi S; Snyder M; Crowley MJ; Feinglos M; Dunn JP
    BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 36170350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How well do self-monitored capillary glucose measurements predict the mean blood glucose from 24-hour continuous monitoring in endocrine practice?
    Gioe O; Chalew SA
    Endocr Pract; 2014 Jul; 20(7):650-6. PubMed ID: 24449666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous Blood Glucose Monitoring Outcomes in Veterans With Type 2 Diabetes.
    Langford SN; Lane M; Karounos D
    Fed Pract; 2021 Nov; 38(Suppl 4):S14-S17. PubMed ID: 35136339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.